Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2pos Breast Cancer
Although immune-based therapies have made remarkable inroads in cancer treatment, they usually must be combined with standard treatment modalities, including cytotoxic drugs, to achieve maximal clinical benefits. As immunotherapies are further advanced and refined, considerable efforts will be requi...
Main Authors: | Nirmala Ghimirey, Chase Steele, Brian J. Czerniecki, Gary K. Koski, Loral E. Showalter |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2021/8818393 |
Similar Items
-
Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib.
by: Loral E Showalter, et al.
Published: (2019-01-01) -
Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2<sup>pos</sup> Breast Cancer
by: Loral E. Showalter, et al.
Published: (2021-09-01) -
Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2<sup>pos</sup> Disease
by: Crystal M. Oechsle, et al.
Published: (2020-02-01) -
CD4+ Th1 to the rescue in HER-2+ breast cancer
by: Lea Lowenfeld, et al.
Published: (2019-10-01) -
Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention
by: Nadia F Nocera, et al.
Published: (2016-10-01)